Gregory A. Rippon, MD, MS
Advertisement
Chief medical partner of neurology, ophthalmology, and internal medicine at Genentech
Articles by Gregory A. Rippon, MD, MS
The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Applying two decades of Alzheimer’s research and doing what’s right for patientsPublished: September 22nd 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Overviewing Promising Phase 1/2 Data of Gene Therapy ETX101 in Dravet Syndrome: Joseph Sullivan, MD
2
Gene Therapy ETX101 Demonstrates Significant Effects on Seizure Reduction, Neurodevelopmental Outcomes in POLARIS Phase 1/2 Program
3
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
4
Inside the 2026 MDA Conference: Keynote Insights and Evolving Neuromuscular Care
5
